Esperion Therapeutics Inc (ESPR)
Cost of Revenue
$146.39M
TTM · Period ending: · USD
ESPR Cost of Revenue
Latest reported$146.39Mperiod ending
Latest reported$146.39Mperiod ending
ESPR TTM Cost of Revenue ($786.06K → $146.39M)
TTM cost of revenue
High-resolution chart · PNG
ESPR cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 146,390,000 | |
| 143,355,000 | |
| 141,132,000 | |
| 102,998,000 | |
| 90,064,000 | |
| 68,601,000 | |
| 54,422,000 | |
| 50,513,000 | |
| 41,690,000 | |
| 43,267,000 | |
| 35,975,000 | |
| 29,104,000 | |
| 31,494,000 | |
| 26,967,000 | |
| 27,882,000 | |
| 26,934,000 | |
| 19,558,000 | |
| 14,217,000 | |
| 10,830,000 | |
| 5,547,000 | |
| 4,145,000 | |
| 2,392,000 | |
| 38,938,000 | |
| 86,944,000 | |
| 129,334,000 | |
| 175,611,000 | |
| 186,850,000 | |
| 180,120,000 | |
| 176,856,000 | |
| 171,488,000 | |
| 269,618,000 | |
| 228,067,000 | |
| 188,543,000 | |
| 147,603,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 742,000 | |
| 1,457,000 | |
| 964,000 | |
| 1,409,000 | |
| 1,096,000 | |
| 786,056 |